Celyad Oncology Reports First Half 2023 Financial Results

Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement...

Related Keywords

Belgium ,United States ,London ,City Of ,United Kingdom ,Walloon Region ,Waals Gewest ,Mont Saint Guibert ,Boston ,Massachusetts ,Parc ,Region Flamande ,American ,Caroline Lonez ,Georges Rawadi ,David Georges ,World Oncology Cell Therapy Congress ,International Conference On Lymphocyte Engineering ,Wrd Communications ,Business Development ,Exchange Commission ,Dartmouth College ,Company Or Celyad Oncology ,Business Development Intellectual Property ,Society For Immunotherapy Of Cancer ,Celdara Medical ,Chief Executive Officer ,Celyad Oncology ,Chief Executive ,Vice President Business Development ,Intellectual Property ,American Depositary Shares ,Nasdaq Global ,Euronext Brussels ,Lancet Haematology Journal ,Immuno Oncology Summit Europe ,Axis Parc ,International Conference ,Lymphocyte Engineering ,San Diego ,Belgium Fixed ,Belgium Mobile ,Private Securities Litigation Reform Act ,Annual Report ,Consolidated Statement ,Comprehensive Income ,Financial Position ,Nasdaq Cyad ,Elyad Oncology Sa ,Business Update ,Biotech ,